Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 10471265

EMD:Ref Document

Bid Value: Ref Document

602 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 10438499

EMD:Ref Document

Bid Value: Ref Document

602 Days Left

Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open House Model For The Active Ingredient Bosutinib Atc Code According To Who L01Ea04

Deadline: 31 Dec 2025

Germany

Ref. No.: 10433370

EMD:Ref Document

Bid Value: Ref Document

237 Days Left

Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open House Model For The Active Ingredient Brinzolamide Timolol Official Atc Code S01Ed67

Deadline: 31 Dec 2026

Germany

Ref. No.: 10433324

EMD:Ref Document

Bid Value: Ref Document

602 Days Left

Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open House Model For The Active Ingredient Tocilizumab Atc Code According To Who L04Ac07

Deadline: 31 Dec 2025

Germany

Ref. No.: 10433093

EMD:Ref Document

Bid Value: Ref Document

237 Days Left

Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open House Model For The Active Ingredient Golimumab Atc Code According To Who L04Ab06

Deadline: 31 Dec 2025

Germany

Ref. No.: 10429130

EMD:Ref Document

Bid Value: Ref Document

237 Days Left

Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open House Model For The Active Ingredient Rotigotine Atc Code According To Who N04Bc09

Deadline: 31 Dec 2026

Germany

Ref. No.: 10428703

EMD:Ref Document

Bid Value: Ref Document

602 Days Left

Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open House Model For The Active Ingredient Infliximab For Subcutaneous Injection Atc Code According To Who L04Ab02

Deadline: 31 Dec 2026

Germany

Ref. No.: 10428274

EMD:Ref Document

Bid Value: Ref Document

602 Days Left

Pharmaceutical Discount Agreements From 01 01 2025 For Various Active Ingredients Within The Framework Of An Open House Procedure

Deadline: 02 Nov 2026

Germany

Ref. No.: 10421797

EMD:Ref Document

Bid Value: Ref Document

543 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Adalimumab

Deadline: 10 Nov 2026

Germany

Ref. No.: 10421330

EMD:Ref Document

Bid Value: Ref Document

551 Days Left

Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Security Code Sgb V By Means Of An Open House Model For The Active Ingredient Tiotropium Bromide Atc Code According To Who R03Bb04

Deadline: 31 Dec 2026

Germany

Ref. No.: 10413949

EMD:Ref Document

Bid Value: Ref Document

602 Days Left

Pharmaceutical And Biomedical Research

Deadline: 01 Mar 2029

United States

Ref. No.: 10412552

EMD:Ref Document

Bid Value: Ref Document

1393 Days Left

Pharmaceutical And Biomedical Research

Deadline: 01 Mar 2029

United States

Ref. No.: 10412551

EMD:Ref Document

Bid Value: Ref Document

1393 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 10402001

EMD:Ref Document

Bid Value: Ref Document

602 Days Left

Framework Agreement For Abi Ngs And Dna Sequencer Chemical Reagents For Financial Year 24 25

Deadline: 30 Jun 2027

Bangladesh

Ref. No.: 10386020

EMD:Ref Document

Bid Value: Ref Document

783 Days Left

Discover Tenders by Pharmaceutical Chemicals Sector

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Discover Tenders by Pharmaceutical Chemicals Sector

Filter Your Search

FREE Trial plan for all new users!